Prognostic value of highly sensitive troponin T on cardiac events in patients with chronic kidney disease not on dialysis

2012 ◽  
Vol 28 (4) ◽  
pp. 473-479 ◽  
Author(s):  
Midori Hasegawa ◽  
Junichi Ishii ◽  
Fumihiko Kitagawa ◽  
Kyoko Kanayama ◽  
Hiroshi Takahashi ◽  
...  
2021 ◽  
Vol 345 ◽  
pp. 19-20
Author(s):  
A.B. Md Radzi ◽  
R.E.F. Raja Shariff ◽  
M.H. Hamidi ◽  
H. Sani ◽  
K.S. Ibrahim ◽  
...  

2017 ◽  
Vol 1 (7) ◽  
Author(s):  
M. Ashry ◽  
Osama Ibrahim ◽  
Ahmed Obiedallah ◽  
Samir Abdulhamid ◽  
Lobna Tag ◽  
...  

2019 ◽  
Vol 37 ◽  
pp. e86
Author(s):  
A.B. M.D. Radzi ◽  
K.S. Ibrahim ◽  
N.Y.C. Chua ◽  
H.A. Zainal Abidin ◽  
R. Najme Khir ◽  
...  

2012 ◽  
Vol 18 (10) ◽  
pp. S178
Author(s):  
Hiroyuki Naruse ◽  
Junnichi Ishii ◽  
Ryuunosuke Okuyama ◽  
Tousei Hashimoto ◽  
Kousuke Hattori ◽  
...  

2011 ◽  
Vol 106 (11) ◽  
pp. 978-984 ◽  
Author(s):  
David Spirk ◽  
Drahomir Aujesky ◽  
Marc Husmann ◽  
Daniel Hayoz ◽  
Thomas Baldi ◽  
...  

SummaryA low simplified Pulmonary Embolism Severity Index (sPESI), defined as age ≤80 years and absence of systemic hypotension, tachycardia, hypoxia, cancer, heart failure, and lung disease, identifies low-risk patients with acute pulmonary embolism (PE). It is unknown whether cardiac troponin testing improves the prediction of clinical outcomes if the sPESI is not low. In the prospective Swiss Venous Thromboembolism Registry, 369 patients with acute PE and a troponin test (conventional troponin T or I, highly sensitive troponin T) were enrolled from 18 hospitals. A positive test result was defined as a troponin level above the manufacturers assay threshold. Among the 106 (29%) patients with low sPESI, the rate of mortality or PE recurrence at 30 days was 1.0%. Among the 263 (71%) patients with high sPESI, 177 (67%) were troponin-negative and 86 (33%) troponin-positive; the rate of mortality or PE recurrence at 30 days was 4.6% vs. 12.8% (p=0.015), respectively. Overall, risk assessment with a troponin test (hazard ratio [HR] 3.39, 95% confidence interval [CI] 1.38–8.37; p=0.008) maintained its prognostic value for mortality or PE recurrence when adjusted for sPESI (HR 5.80, 95%CI 0.76–44.10; p=0.09). The combination of sPESI with a troponin test resulted in a greater area under the receiver-operating characteristic curve (HR 0.72, 95% CI 0.63–0.81) than sPESI alone (HR 0.63, 95% CI 0.57–0.68) (p=0.023). In conclusion, although cardiac troponin testing may not be required in patients with a low sPESI, it adds prognostic value for early death and recurrence for patients with a high sPESI.


Sign in / Sign up

Export Citation Format

Share Document